Form D — ABK Biomedical Inc
0001879785-25-000032 · filed May 13, 2025
Offering
- Industry
- Other
- Exemptions
- 06b
- Total offering
- $26,093,999
- Total sold
- $26,093,999
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- ABK Biomedical Inc
- CIK
- 1773773
- Entity
- Corporation
- Jurisdiction
- NOVA SCOTIA, CANADA
- Year incorporated
- —
- Address
- 155 CHAIN LAKE DRIVE, UNIT 32
HALIFAX, A5 B3S 1B3 - Phone
- 902-442-4009
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Michael Mangano · Executive OfficerHalifax, A5 Find on LinkedIn ↗
-
Gary Donofrio · Executive OfficerHalifax, A5 Find on LinkedIn ↗
-
Mike Tyson · Executive OfficerHalifax, A5 Find on LinkedIn ↗
-
Aravind Arepally · Executive OfficerHalifax, A5 Find on LinkedIn ↗
-
Marc Gregoire · Executive OfficerHalifax, A5 Find on LinkedIn ↗
-
David Dobrowsky · Executive OfficerHalifax, A5 Find on LinkedIn ↗
-
Anthony Headley · Executive OfficerHalifax, A5 Find on LinkedIn ↗
-
Aaron Berez · DirectorHalifax, A5 Find on LinkedIn ↗
-
Keten Patel · DirectorHalifax, A5 Find on LinkedIn ↗
-
Carissa Bellardine Black · DirectorHalifax, A5 Find on LinkedIn ↗
-
James Eadie · DirectorHalifax, A5 Find on LinkedIn ↗
-
Joseph Siletto · DirectorHalifax, A5 Find on LinkedIn ↗
-
James McLaren · DirectorHalifax, A5 Find on LinkedIn ↗
-
Lucy Bataneant · Executive OfficerHalifax, A5 Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗